Skip to search formSkip to main contentSkip to account menu

AVX-470

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Tu1297 Penetration of AVX-470, a Bovine-Derived Orally Administered Anti-TNF Antibody, Into Colon Mucosal Tissue in Patients With Ulcerative Colitis
2014
2014
Sa2004 Effects of AVX-470m, an Oral Polyclonal Anti-TNF Antibody, on Survival and Biomarkers in a Murine Model of Gastrointestinal Acute Radiation Syndrome
2014
2014
Anti-MAdCAM Antibody PF-00547659 in Crohn’s Disease: Final Efficacy Results From the Open-Label TOSCA Study
D’Haens Geert, Reinisch Walter, Vermeire Severine, Allez Matthieu, Vogelsang Harald, Van Gossum Andre, Baumgart Daniel… 
2014
2014
Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of AVX-470, an Oral, Bovine-Derived Anti-TNF Antibody, in Patients With Active Ulcerative Colitis (UC): Initial Human Experience: 1668
2014
2014
P-103 Modulation of Inflammatory and Disease Biomarkers Following 4 Week Treatment with AVX-470, an Oral Anti-TNF Antibody, in Ulcerative Colitis Patients
2014
2014
Microbiota stability in vivo and in vitro
Conclusions: These data show a strong correlation of inflammatory responses between the colitis and radiationinduced models of GI… 
2014
2014
P042 Microbiota stability in vivo and in vitro
2013
2013
Tu1662 AVX-470: A Novel Orally-Administered Anti-TNF Antibody Therapeutic for IBD: In Vitro Pharmacology
2012
2012
In Vitro Pharmacology of AVX‐470, an Oral Anti‐TNF Polyclonal Antibody for the Treatment of IBD: P‐203
(human homologue is IL-8) in Tg-villin-MMP9 compared to WT mice. Organ culture ELISA showed significantly increased expression of… 
2012
2012
Oral Administration of AVX-470m, A Novel Anti-TNF Antibody, Suppresses Inflammation in a Murine Model of Inflammatory Bowel Disease: 1627
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)